Cargando…

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors

INTRODUCTION: Cardiovascular events are common in COVID-19. While the use of anticoagulation during hospitalization has been established in current guidelines, recommendations regarding antithrombotic therapy in the post-discharge period are conflicting. METHODS: To investigate this issue, we conduc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Motloch, Lukas J., Jirak, Peter, Mirna, Moritz, Fiedler, Lukas, Davtyan, Paruir A., Lakman, Irina A., Gareeva, Diana F., Tyurin, Anton V., Gumerov, Ruslan M., Matskeplishvili, Simon T., Pavlov, Valentin N., Cai, Benzhi, Kopp, Kristen, Topf, Albert, Hoppe, Uta C., Pistulli, Rudin, Zagidullin, Naufal S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372296/ https://www.ncbi.nlm.nih.gov/pubmed/35966512 http://dx.doi.org/10.3389/fcvm.2022.916156

Ejemplares similares

Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 Pneumonia
por: Motloch, Lukas J., et al.
Publicado: (2022)

SERUM BIOMARKERS HS-TNI AND SST-2 PREDICT LONG-TERM RISK FOR CARDIOVASCULAR EVENTS IN DISCHARGED HOSPITALIZED COVID-19 SURVIVORS
por: Zagidullin, Naufal, et al.
Publicado: (2023)

Investigation of hs-TnI and sST-2 as Potential Predictors of Long-Term Cardiovascular Risk in Patients with Survived Hospitalization for COVID-19 Pneumonia
por: Fiedler, Lukas, et al.
Publicado: (2022)

Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors
por: Fiedler, Lukas, et al.
Publicado: (2023)

J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality?
por: Zagidullin, Naufal Shamilevich, et al.
Publicado: (2021)

SERUM BIOMARKERS IN MORTALITY RISK STRATIFICATION IN PATIENTS, HOSPITALIZED WITH COVID-19 PNEUMONIA IN EARLY AND REMOTE PERIOD
por: Zagidullin, Naufal, et al.
Publicado: (2022)

OSBORNE WAVE IN ECG AS A PREDICTOR OF HOSPITAL MORTALITY IN COVID-19 ASSOCIATED PNEUMONIA
por: Zagidullin, Naufal, et al.
Publicado: (2021)

Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction
por: Zagidullin, Naufal, et al.
Publicado: (2020)

Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine
por: Ohnewein, Bernhard, et al.
Publicado: (2023)

Pathophysiology of Calcium Mediated Ventricular Arrhythmias and Novel Therapeutic Options with Focus on Gene Therapy
por: Paar, Vera, et al.
Publicado: (2019)

Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies
por: Topf, Albert, et al.
Publicado: (2021)

Gender-Specific Differences in the Intensive Care Treatment of COVID-19 Patients
por: Jirak, Peter, et al.
Publicado: (2022)

Impact of cavotricuspid isthmus ablation for typical atrial flutter and heart failure in the elderly—results of a retrospective multi-center study
por: Boxhammer, Elke, et al.
Publicado: (2023)

Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome
por: Topf, Albert, et al.
Publicado: (2022)

Editorial: Cardio-Protection and Heart Repair: New Drugs, Targets and Approaches
por: Zagidullin, Naufal, et al.
Publicado: (2021)

Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter Analysis
por: Jirak, Peter, et al.
Publicado: (2022)

The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy
por: Topf, Albert, et al.
Publicado: (2020)

Higher Incidence of Stroke in Severe COVID-19 Is Not Associated With a Higher Burden of Arrhythmias: Comparison With Other Types of Severe Pneumonia
por: Jirak, Peter, et al.
Publicado: (2021)

Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls
por: Jirak, Peter, et al.
Publicado: (2020)

Differences of Hemogram Parameters and Their Ratios among Patients with Takotsubo Syndrome, Acute Coronary Syndrome and Healthy Individuals
por: Topf, Albert, et al.
Publicado: (2022)

Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration
por: Gong, Rui, et al.
Publicado: (2021)

Exercise-related T-wave oversensing: an underestimated cause of reduced exercise capacity in a pacemaker-dependent patient—a case report and review of the literature
por: Topf, Albert, et al.
Publicado: (2020)

Subcutaneous administration of levothyroxine: a novel approach to refractory hypothyroidism – A review and a case report
por: Topf, Albert, et al.
Publicado: (2021)

Antithrombotic treatment patterns in patients with atrial fibrillation in Italy pre- and post-DOACs: the REPAIR study
por: Esposti, Luca D, et al.
Publicado: (2019)

Differential Diagnosis between Takotsubo Syndrome and Acute Coronary Syndrome—A Prospective Analysis of Novel Cardiovascular Biomarkers for a More Selective Triage
por: Topf, Albert, et al.
Publicado: (2022)

Ivabradine Prevents Heart Rate Acceleration in Patients with Chronic Obstructive Pulmonary Disease and Coronary Heart Disease after Salbutamol Inhalation
por: Zulkarneev, Rustem, et al.
Publicado: (2012)

The Value of Fetuin-A as a Predictor to Identify Takotsubo Patients at Risk of Cardiovascular Events
por: Topf, Albert, et al.
Publicado: (2021)

Myocardial injury in severe COVID‐19 is similar to pneumonias of other origin: results from a multicentre study
por: Jirak, Peter, et al.
Publicado: (2020)

Management of Implantable Cardioverter-Defibrillators during Pregnancy—A Systematic Review
por: Topf, Albert, et al.
Publicado: (2021)

Case report: Short-long-short mechanism triggering sustained ventricular tachycardia in a patient with a single-chamber ICD but inhibiting antitachycardia therapy
por: Schernthaner, Christiana, et al.
Publicado: (2022)

Autoimmune myocarditis is not associated with left ventricular systolic dysfunction
por: Mirna, Moritz, et al.
Publicado: (2019)

Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: new regulators and its implications
por: Guo, Xiaofei, et al.
Publicado: (2018)

Neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio predict length of hospital stay in myocarditis
por: Mirna, Moritz, et al.
Publicado: (2021)

Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials
por: Mirna, Moritz, et al.
Publicado: (2021)

Tumor necrosis factor alpha—an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?
por: Mirna, Moritz, et al.
Publicado: (2021)

Classic and Novel Biomarkers as Potential Predictors of Ventricular Arrhythmias and Sudden Cardiac Death
por: Shomanova, Zornitsa, et al.
Publicado: (2020)

A Novel Clinical Score for Differential Diagnosis Between Acute Myocarditis and Acute Coronary Syndrome – The SAlzburg MYocarditis (SAMY) Score
por: Mirna, Moritz, et al.
Publicado: (2022)

Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening Tests
por: Favresse, Julien, et al.
Publicado: (2018)

Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?
por: Hardy, Michael, et al.
Publicado: (2022)

The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome
por: Topf, Albert, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dul1n29pq65et39n7km5c8o3mc